Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,1-dichloroethene | decreases expression | EXP | | 6480464 | vinylidene chloride results in decreased expression of MOB3B mRNA | CTD | PMID:26682919 | 1,2-dichloroethane | decreases expression | EXP | | 6480464 | ethylene dichloride results in decreased expression of MOB3B mRNA | CTD | PMID:28960355 | 1,2-dimethylhydrazine | decreases expression | EXP | | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of MOB3B mRNA | CTD | PMID:22206623 | 17beta-estradiol | multiple interactions | ISO | MOB3B (Homo sapiens) | 6480464 | [Estradiol co-treated with TGFB1 protein] results in increased expression of MOB3B mRNA | CTD | PMID:30165855 | 17beta-estradiol | decreases expression | ISO | Mob3b (Rattus norvegicus) | 6480464 | Estradiol results in decreased expression of MOB3B mRNA | CTD | PMID:32145629 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | MOB3B (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin affects the expression of MOB3B mRNA | CTD | PMID:22298810 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of MOB3B mRNA | CTD | PMID:26290441 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of MOB3B mRNA | CTD | PMID:21570461 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | MOB3B (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of MOB3B mRNA | CTD | PMID:28628672 | 6-propyl-2-thiouracil | decreases expression | ISO | Mob3b (Rattus norvegicus) | 6480464 | Propylthiouracil results in decreased expression of MOB3B mRNA | CTD | PMID:24780913 | aflatoxin B1 | decreases expression | ISO | MOB3B (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased expression of MOB3B mRNA | CTD | PMID:27153756 | aflatoxin B1 | decreases methylation | ISO | MOB3B (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of MOB3B gene | CTD | PMID:27153756 | all-trans-retinoic acid | decreases expression | ISO | MOB3B (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of MOB3B mRNA | CTD | PMID:21934132 | amphetamine | decreases expression | ISO | Mob3b (Rattus norvegicus) | 6480464 | Amphetamine results in decreased expression of MOB3B mRNA | CTD | PMID:30779732 | aristolochic acid A | decreases expression | ISO | MOB3B (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of MOB3B mRNA | CTD | PMID:33212167 | arsenite(3-) | increases methylation | ISO | MOB3B (Homo sapiens) | 6480464 | arsenite results in increased methylation of MOB3B promoter | CTD | PMID:23974009 | benzo[a]pyrene | decreases expression | ISO | MOB3B (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of MOB3B mRNA | CTD | PMID:20064835 | benzo[a]pyrene | affects methylation | ISO | MOB3B (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of MOB3B 5' UTR | CTD | PMID:27901495 | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of MOB3B mRNA | CTD | PMID:21964900 | benzo[a]pyrene | increases expression | ISO | MOB3B (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of MOB3B mRNA | CTD | PMID:22316170 | benzo[a]pyrene diol epoxide I | decreases expression | ISO | MOB3B (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:19150397 | bis(2-ethylhexyl) phthalate | decreases expression | EXP | | 6480464 | Diethylhexyl Phthalate results in decreased expression of MOB3B mRNA | CTD | PMID:19850644 | bis(2-ethylhexyl) phthalate | multiple interactions | EXP | | 6480464 | PPARA protein promotes the reaction [Diethylhexyl Phthalate results in decreased expression of MOB3B mRNA] | CTD | PMID:19850644 | bisphenol A | decreases expression | ISO | Mob3b (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of MOB3B mRNA | CTD | PMID:25181051 and PMID:34947998 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of MOB3B mRNA | CTD | PMID:33221593 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of MOB3B mRNA | CTD | PMID:34585602 | bisphenol A | affects expression | ISO | Mob3b (Rattus norvegicus) | 6480464 | bisphenol A affects the expression of MOB3B mRNA | CTD | PMID:32145629 | bisphenol A | multiple interactions | ISO | MOB3B (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of MOB3B mRNA | CTD | PMID:28628672 | bisphenol A | increases methylation | ISO | Mob3b (Rattus norvegicus) | 6480464 | bisphenol A results in increased methylation of MOB3B gene | CTD | PMID:28505145 | butanal | increases expression | ISO | MOB3B (Homo sapiens) | 6480464 | butyraldehyde results in increased expression of MOB3B mRNA | CTD | PMID:26079696 | cadmium dichloride | increases methylation | ISO | Mob3b (Rattus norvegicus) | 6480464 | Cadmium Chloride results in increased methylation of MOB3B promoter | CTD | PMID:22457795 | carbon nanotube | decreases expression | EXP | | 6480464 | Nanotubes more ... | CTD | PMID:25620056 | chlordecone | decreases expression | EXP | | 6480464 | Chlordecone results in decreased expression of MOB3B mRNA | CTD | PMID:33711761 | cisplatin | multiple interactions | ISO | MOB3B (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in decreased expression of MOB3B mRNA | CTD | PMID:27392435 | cisplatin | decreases expression | ISO | MOB3B (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of MOB3B mRNA | CTD | PMID:27392435 | copper atom | multiple interactions | ISO | MOB3B (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of MOB3B mRNA | CTD | PMID:20971185 | copper(0) | multiple interactions | ISO | MOB3B (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of MOB3B mRNA | CTD | PMID:20971185 | copper(II) sulfate | increases expression | EXP | | 6480464 | Copper Sulfate results in increased expression of MOB3B mRNA | CTD | PMID:18579281 | CU-O LINKAGE | decreases expression | ISO | MOB3B (Homo sapiens) | 6480464 | cupric oxide results in decreased expression of MOB3B mRNA | CTD | PMID:22077320 | Cuprizon | increases expression | ISO | Mob3b (Rattus norvegicus) | 6480464 | Cuprizone results in increased expression of MOB3B mRNA | CTD | PMID:26577399 | cyclosporin A | decreases expression | ISO | MOB3B (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of MOB3B mRNA | CTD | PMID:20106945 | cyclosporin A | increases expression | ISO | MOB3B (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of MOB3B mRNA | CTD | PMID:27989131 | dexamethasone | multiple interactions | ISO | MOB3B (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of MOB3B mRNA | CTD | PMID:28628672 | diazinon | increases methylation | ISO | MOB3B (Homo sapiens) | 6480464 | Diazinon results in increased methylation of MOB3B gene | CTD | PMID:22964155 | dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of MOB3B mRNA | CTD | PMID:21266533 | dioxygen | multiple interactions | EXP | | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MOB3B mRNA | CTD | PMID:30529165 | disodium selenite | increases expression | ISO | MOB3B (Homo sapiens) | 6480464 | Sodium Selenite results in increased expression of MOB3B mRNA | CTD | PMID:18175754 | dorsomorphin | multiple interactions | ISO | MOB3B (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | endosulfan | increases expression | ISO | Mob3b (Rattus norvegicus) | 6480464 | Endosulfan results in increased expression of MOB3B mRNA | CTD | PMID:29391264 | entinostat | decreases expression | ISO | MOB3B (Homo sapiens) | 6480464 | entinostat results in decreased expression of MOB3B mRNA | CTD | PMID:26272509 | entinostat | multiple interactions | ISO | MOB3B (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MOB3B mRNA | CTD | PMID:27188386 | fenthion | increases expression | EXP | | 6480464 | Fenthion results in increased expression of MOB3B mRNA | CTD | PMID:34813904 | furan | increases expression | EXP | | 6480464 | furan results in increased expression of MOB3B mRNA | CTD | PMID:24183702 | gentamycin | decreases expression | ISO | Mob3b (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of MOB3B mRNA | CTD | PMID:33387578 | hydroquinone | decreases expression | ISO | MOB3B (Homo sapiens) | 6480464 | hydroquinone results in decreased expression of MOB3B mRNA | CTD | PMID:31256213 | indometacin | multiple interactions | ISO | MOB3B (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of MOB3B mRNA | CTD | PMID:28628672 | manganese(II) chloride | increases expression | ISO | Mob3b (Rattus norvegicus) | 6480464 | manganese chloride results in increased expression of MOB3B mRNA | CTD | PMID:28801915 | methidathion | increases expression | EXP | | 6480464 | methidathion results in increased expression of MOB3B mRNA | CTD | PMID:34813904 | methylmercury chloride | decreases expression | ISO | MOB3B (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of MOB3B mRNA | CTD | PMID:28001369 | N-methyl-4-phenylpyridinium | decreases expression | ISO | MOB3B (Homo sapiens) | 6480464 | 1-Methyl-4-phenylpyridinium results in decreased expression of MOB3B mRNA | CTD | PMID:24810058 | nickel atom | increases expression | ISO | MOB3B (Homo sapiens) | 6480464 | Nickel results in increased expression of MOB3B mRNA | CTD | PMID:25583101 | paracetamol | decreases expression | ISO | Mob3b (Rattus norvegicus) | 6480464 | Acetaminophen results in decreased expression of MOB3B mRNA | CTD | PMID:33387578 | pentanal | increases expression | ISO | MOB3B (Homo sapiens) | 6480464 | pentanal results in increased expression of MOB3B mRNA | CTD | PMID:26079696 | perfluorooctane-1-sulfonic acid | decreases expression | ISO | MOB3B (Homo sapiens) | 6480464 | perfluorooctane sulfonic acid results in decreased expression of MOB3B mRNA | CTD | PMID:27153767 | pirinixic acid | multiple interactions | ISO | MOB3B (Homo sapiens) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of MOB3B mRNA | CTD | PMID:19710929 | potassium chromate | increases expression | ISO | MOB3B (Homo sapiens) | 6480464 | potassium chromate(VI) results in increased expression of MOB3B mRNA | CTD | PMID:22714537 | progesterone | increases expression | ISO | MOB3B (Homo sapiens) | 6480464 | Progesterone results in increased expression of MOB3B mRNA | CTD | PMID:20864642 | propanal | increases expression | ISO | MOB3B (Homo sapiens) | 6480464 | propionaldehyde results in increased expression of MOB3B mRNA | CTD | PMID:26079696 | SB 431542 | multiple interactions | ISO | MOB3B (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | silicon dioxide | increases expression | ISO | MOB3B (Homo sapiens) | 6480464 | Silicon Dioxide analog results in increased expression of MOB3B mRNA | CTD | PMID:25895662 | silicon dioxide | decreases expression | EXP | | 6480464 | Silicon Dioxide results in decreased expression of MOB3B mRNA | CTD | PMID:23221170 | sodium arsenite | increases expression | ISO | MOB3B (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of MOB3B mRNA | CTD | PMID:34032870 | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of MOB3B mRNA | CTD | PMID:36209798 | Soman | increases expression | ISO | Mob3b (Rattus norvegicus) | 6480464 | Soman results in increased expression of MOB3B mRNA | CTD | PMID:19281266 | sulforaphane | decreases expression | ISO | MOB3B (Homo sapiens) | 6480464 | sulforaphane results in decreased expression of MOB3B mRNA | CTD | PMID:31838189 | tetrachloromethane | decreases expression | ISO | Mob3b (Rattus norvegicus) | 6480464 | Carbon Tetrachloride results in decreased expression of MOB3B mRNA | CTD | PMID:31150632 | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of MOB3B mRNA | CTD | PMID:31919559 | tremolite asbestos | increases expression | EXP | | 6480464 | tremolite results in increased expression of MOB3B mRNA | CTD | PMID:29279043 | trichostatin A | decreases expression | ISO | MOB3B (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of MOB3B mRNA | CTD | PMID:24935251 and PMID:26272509 | trichostatin A | multiple interactions | ISO | MOB3B (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MOB3B mRNA | CTD | PMID:27188386 | troglitazone | decreases expression | EXP | | 6480464 | troglitazone results in decreased expression of MOB3B mRNA | CTD | PMID:28973697 | trovafloxacin | decreases expression | EXP | | 6480464 | trovafloxacin results in decreased expression of MOB3B mRNA | CTD | PMID:35537566 | valproic acid | decreases methylation | ISO | MOB3B (Homo sapiens) | 6480464 | Valproic Acid results in decreased methylation of MOB3B gene | CTD | PMID:29154799 | valproic acid | decreases expression | ISO | MOB3B (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of MOB3B mRNA | CTD | PMID:28001369 | valproic acid | increases expression | ISO | MOB3B (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of MOB3B mRNA | CTD | PMID:23179753 and PMID:27188386 | valproic acid | affects expression | ISO | MOB3B (Homo sapiens) | 6480464 | Valproic Acid affects the expression of MOB3B mRNA | CTD | PMID:25979313 | vinclozolin | decreases expression | ISO | Mob3b (Rattus norvegicus) | 6480464 | vinclozolin results in decreased expression of MOB3B mRNA | CTD | PMID:23869203 | |